ALR Technologies SG Ltd. heads into its May 1 earnings event with more questions than answers — a micro-cap health care equipment name trading at $0.0177, with data gaps across nearly every key metric and an ownership structure dominated almost entirely by two individuals.
The most telling feature of this stock is not its positioning but its structure. Two holders, Christine Y. S. Kan and Sidney S. Chan, control a combined 59.4% of shares — roughly 30% and 29% each. A small adjustment in March showed Chan trimming 500,000 shares while Kan added the same amount. That symmetry likely reflects an internal transfer rather than a market signal. Beyond that top pair, institutional ownership thins out fast: the remaining four named holders together account for less than 1% of shares outstanding.
Short interest is technically negligible and the data is stale. FINRA's most recent fortnightly report, dated April 15, shows just 50 shares short — functionally zero. The older ORTEX estimate from September 2025 places short interest at roughly 166,000 shares, or about 0.03% of the free float. Neither reading points to any meaningful short position. Borrow availability is not a story here; it never has been for a stock this thinly traded.
The price chart tells a more interesting story than the lending market does. The stock rose nearly 50% over the past month to reach $0.0177, though it has been flat for the past week. That kind of move in a sub-two-cent OTC name can reflect very thin liquidity rather than fundamental re-rating. A small number of trades at these price levels can produce large percentage swings.
The earnings history offers a mixed picture. The last three results produced a 1-day move of –1.3%, –4.3%, and –13.6% respectively. Only the August 2025 print bucked the pattern, with a 5.6% gain on the day that extended to a 41% gain over five sessions. With the next event scheduled for May 1, that asymmetry in historical reactions — three down, one sharply up — is the relevant setup context, though the sparse and irregular reporting cadence makes any pattern-reading difficult.
The short score rank sits in the 96th percentile, but this is a function of how the score weights thin borrow activity relative to a small float — it does not reflect meaningful short-side pressure. The dividend score of 28 is low, consistent with a development-stage micro-cap. There is no analyst coverage, no options data, and no cost-to-borrow activity worth discussing. What to watch on May 1 is straightforward: whether the company provides any revenue or operational update that could justify the recent price move, and whether the two dominant shareholders show any change in stance in the filings that follow.
See the live data behind this article on ORTEX.
Open ALRT.F on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
